Please, please someone put me I touch with the person responsible for the word BAMLANIVIMAB. https://twitter.com/business/status/1325950862666166275
OK, I've actually been doing research on this, and there are set nomenclature rules for monoclonal antibody drugs. All of them end in "MAB" and there are a bunch of kinds. The letters just before the MAB tell you what the drug focuses on.
So, if they're focused on cardiovacsular disease, the compound ends in "cimab" and for fungal diseases it's "fungmab" and bone is "osmab."

And, if you're working on viruses...VIMAB!
So "vimab" is explained...which just leaves "Bamlani" which, a quick Goole search shows is a not super uncommon last name. But another search shows no person at Eli Lilly with that name.
So maybe there is a secret Bamlani...or maybe it's a combination of names, lab names, locations, or something to do with the physiology / biochemistry / method of action of the drug. I WILL GET TO THE BOTTOM OF THIS! Send me tips!!
Update...I will have an update in the future. I'M SLEUTHING REAL GOOD.
You can follow @hankgreen.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.